SPRY
ARS Pharmaceuticals, Inc.
-0.01 (-0.24%)4.16USD584K成交股數413M市值–本益比(近四季)3.5股價營收比+114.2%營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 33.7M+322% | 22.7M-74% | 32.5M+1472% | 15.7M+3043% | 8.0M | 86.6M | 2.1M+20580% | 500K+2400% | 0.00 | 0.00 | 10K | 20K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.7M | 4.3M | 2.8M | 4.0M | 3.0M | 3.0M | 4.4M | 6.9M | 5.2M | 3.0M | 7.3M | 6.6M |
| 銷售管理費用 | 77.6M | 72.2M | 74.8M | 54.3M | 41.1M | 35.5M | 19.3M | 8.9M | 8.0M | 15.0M | 181K | 337K |
| 營業利益 | −61.5M+65% | −60.1M-227% | −53.2M+145% | −47.6M+210% | −37.2M+182% | 47.2M-363% | −21.7M+6% | −15.3M-18% | −13.2M | −18.0M | −20.6M | −18.7M |
| 營業利益率 | -182.6% | -265.2% | -163.7% | -302.9% | -466.3% | 54.5% | -1,051.6% | -3,068.0% | – | – | -206,030.0% | -93,565.0% |
| 稅後淨利 | −62.3M+84% | −60.6M-221% | −51.2M+167% | −44.9M+259% | −33.9M+230% | 49.9M-436% | −19.1M+10% | −12.5M-16% | −10.3M | −14.9M | −17.4M | −15.0M |
| 淨利率 | -185.2% | -267.3% | -157.4% | -285.6% | -425.7% | 57.7% | -925.0% | -2,503.2% | – | – | -173,700.0% | -74,805.0% |
| 稀釋 EPS | -0.63+80% | -0.61-217% | -0.52+160% | -0.46+254% | -0.35+218% | 0.52-425% | -0.20+11% | -0.13-19% | -0.11 | -0.16 | -0.18 | -0.16 |
| 稀釋股數 | 99.3M | 99.3M | 98.8M | 98.4M | 98.1M | 102M | 97.0M | 96.8M | 96.5M | 95.6M | 94.9M | 94.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.2M | 24.3M | 59.6M | 51.5M | 39.9M | 50.8M | 39.7M | 36.6M | 56.0M | 60.5M | 119M | 87.9M |
| 應收帳款 | 46.8M | 28.7M | 36.5M | 25.1M | 9.3M | 8.2M | 773K | – | – | – | – | – |
| 存貨 | 30.7M | 32.0M | 21.4M | 22.1M | 7.3M | 10.5M | 715K | – | – | 0.00 | – | – |
| 總資產 | 249M | 288M | 373M | 313M | 327M | 351M | 218M | 222M | 228M | 249M | 259M | 271M |
| 有息負債 | 96.7M | 96.5M | 96.2M | – | – | 0.00 | – | – | – | – | – | – |
| 總負債 | 237M | 226M | 225M | 121M | 98.3M | 94.4M | 16.6M | 6.7M | 3.7M | 11.3M | 10.2M | 10.0M |
| 股東權益 | 12.5M | 61.3M | 148M | 192M | 229M | 257M | 201M | 215M | 224M | 237M | 249M | 261M |
| 負債比 | 95.0% | 78.7% | 60.4% | 38.6% | 30.0% | 26.9% | 7.6% | 3.0% | 1.6% | 4.5% | 3.9% | 3.7% |
| 淨現金(現金 − 有息負債) | −88.5M | −72.2M | −36.7M | – | – | 50.8M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −44.9M | – | – | −40.7M+507% | – | – | – | −6.7M | – | – | −12.4M |
| 資本支出 | – | 0.00 | – | – | 91K | – | – | – | 83K | – | – | 193K |
| 自由現金流 | – | −44.9M | – | – | −40.8M+501% | – | – | – | −6.8M | – | – | −12.6M |
| 折舊攤銷 | – | 397K | – | – | 280K | – | 100K | – | 11K | 100K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -198.2% | – | – | -512.1% | – | – | – | – | – | – | -63,110.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 84.3M
| 美國 | 72.2M | 85.7% | +895.1% |
|---|---|---|---|
| 美國以外 | 12.1M | 14.3% | -85.2% |
產品／服務2025 年度 · 84.3M
| 產品 | 72.2M | 85.7% | +895.1% |
|---|---|---|---|
| Revenue Under Collaboration Agreements | 9.7M | 11.5% | -88.1% |
| Revenue Under Supply Agreements | 2.4M | 2.8% | +549.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 84.3M | -5.5% | −171M | -203.3% | -1.74 | −171M |
| FY2024 | 89.1M | +297063.3% | 8.0M | 9.0% | 0.08 | 13.0M |
| FY2023 | 30K | -97.7% | −54.4M | -181,216.7% | -0.57 | −59.4M |
| FY2022 | 1.3M | -76.1% | −34.7M | -2,635.4% | -0.87 | −40.3M |
| FY2021 | 5.5M | -19086.2% | −20.2M | -367.7% | -0.70 | −17.6M |
| FY2020 | −29K | – | −32.9M | 113,610.3% | -11.33 | −32.1M |